The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.

Citation data:

Journal of proteomics, ISSN: 1876-7737, Vol: 156, Page: 94-103

Publication Year:
Usage 175
Abstract Views 166
Link-outs 8
Clicks 1
Captures 11
Readers 10
Exports-Saves 1
Social Media 141
Shares, Likes & Comments 136
Tweets 5
Citations 3
Citation Indexes 3
Abbaoui, Besma; Telu, Kelly H; Lucas, Christopher R; Thomas-Ahner, Jennifer M; Schwartz, Steven J; Clinton, Steven K; Freitas, Michael A; Mortazavi, Amir
Elsevier BV
Biochemistry, Genetics and Molecular Biology
Most Recent Tweet View All Tweets
article description
Cruciferous vegetable intake is associated with reduced risk of bladder cancer, yet mechanisms remain unclear. Cruciferous vegetable isothiocyanates (ITCs), namely sulforaphane (SFN) and erucin (ECN), significantly inhibit histone deacetylase (HDAC) activity in human bladder cancer cells representing superficial to invasive biology (59-83% inhibition with 20μM, 48h treatment), and in bladder cancer xenografts (59±3% ECN inhibition). Individual HDACs inhibited by SFN and ECN include HDACs 1, 2, 4 and 6. Interestingly, global acetylation status of histones H3 or H4 remain unaltered. The interplay between HDAC inhibition and modest modulation of AcH3 and AcH4 status is partially explained by decreased histone acetyl transferase activity (48.8±5.3%). In contrast, a significant decrease in phosphorylation status of all isoforms of histone H1 was observed, concomitant with increased phosphatase PP1β and PP2A activity. Together, these findings suggest that ITCs modulate histone status via HDAC inhibition and phosphatase enhancement. This allows for reduced levels of histone H1 phosphorylation, a marker correlated with human bladder cancer progression. Therefore, ITC-mediated inhibition of histone H1 phosphorylation presents a novel direction of research in elucidating epidemiological relationships and supports future food-based prevention strategies.